A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Überexpression des Vaskulären Endothelialen Wachstumsfaktor Rezeptor 2 (VEGFR2) bei Langzeitüberlebenden eines fortgeschrittenen serösen Ovarialkarzinoms
[thesis]
2020
Objective: The prognosis for high-grade serous ovarian cancer (HGSOC) patients is poor. There are no defined biomarkers to identify between good and poor prognosis at the present. This study is to analyze if there are differences in angiogenesis biomarkers between long-term survivors and poor survivors, using tumor samples from a large cohort of long-term survivors and matched controls. Methods: Tumor samples of 62 "long-term survivors" and 62 matched controls were identified from the Tumor
doi:10.17169/refubium-27718
fatcat:upb45d55zbbjbbsl775iujwore